Kestra Medical Technologies Conquers a $10 Billion Market in the USA with Wearable Defibrillators!

The medical technology company Kestra Medical Technologies (KMTS) completed its IPO in March 2025 and aims to protect at-risk patients from sudden cardiac arrest (SCA). The core product is the ASSURE Wearable Cardioverter Defibrillator (WCD), a portable defibrillator that can be worn under everyday clothing and delivers a shock directly when needed. Currently, there is only one competing product on the market, the ZOLL LiveVest, which is expected to surpass in terms of comfort and significantly lower false alarms. The WCD market presents a $10 billion...